Pharmafile Logo
Pharmafocus logo
Advanced Search

US purchases further 200M Pfizer vaccines for children and possible boosters

July 26, 2021
Sales and Marketing

The Biden administration has purchased an additional 200 million Pfizer-BioNTech COVID-19 vaccines for children, as well as for potential booster …

News

15-minute Covid-19 immune status test launched in the UK and Ireland

July 26, 2021
Sales and Marketing

Luas Diagnostics has launched a 15-minute test to determine immunity to Covid-19 post infection or vaccination. The product, which is …

News

Moderna jab approved for children aged 12-17 in the EU

July 26, 2021
Sales and Marketing

The EU has approved the use of the Moderna COVID vaccine in children aged 12-17. Pfizer’s jab got the green …

News
mask-4898571_1280

Latest UK figures show COVID cases are falling

July 26, 2021
Sales and Marketing

The number of people testing positive with COVID-19 is falling in the UK. The UK recorded 29,173 new cases on …

News

FDA approves Beximco Pharma’s muscle relaxant drug Baclofen

July 26, 2021
Sales and Marketing

Beximco Pharma has received FDA approval for Baclofen (10 and 20 mg tablets). Baclofen is a muscle relaxant drug indicated …

News

New NICE guideline on C. difficile rejects metronidazole prescription

July 23, 2021
Medical Communications

NICE has published a new guideline covering C. difficile infection, the latest in the series of antimicrobial prescribing guidelines which …

News
pfizer_building_logo2_1

Eight-week vaccine gap with Pfizer is best for antibodies

July 23, 2021
Medical Communications

UK researchers have found an eight-week gap between first and second doses of the Pfizer-BioNTech appears to be the “sweet …

News

Expansion for first FDA-approved video game for ADHD treatment

July 23, 2021
Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …

News

Biogen pens open letter to Alzheimer’s community

July 23, 2021
Medical Communications

In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …

News

Parents warned as child respiratory illness on the rise this summer

July 23, 2021
Medical Communications

Parents are being warned to be on the lookout for signs of a common childhood respiratory illness, RSV, as cases …

News
cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …

News

Bayer/MSD heart failure drug gains EC approval

July 22, 2021

The European Commission (EC) has approved MSD and Bayer’s Verquvo (vericiguat) for the treatment of symptomatic chronic heart failure in …

News

China rejects a second WHO probe into COVID outbreak origin

July 22, 2021
COVID-19, China

China has rejected WHO plans for a second investigation into the origin of the coronavirus pandemic, which includes the hypothesis …

News
roche__tree

Roche discussing potential Alzheimer’s treatment with FDA

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …

News

NICE approves treatment for rare bile duct cancer

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …

News
catalent

$100 million expansion planned for Catalent’s Italian vaccine plant

July 21, 2021
Manufacturing and Production, Research and Development

Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …

News

Former FDA adviser calls for further investigation into Alzheimer’s drug

July 21, 2021
Research and Development

A former FDA advisor who resigned after the controversial approval of Biogen’s Alzheimer’s drug has called for a wider probe …

News

Exscientia and Apeiron announce joint oncology venture

July 21, 2021
Research and Development

AI pharmatech company, Exscientia, has announced a collaboration with Shanghai-based GT Apeiron Therapeutics, which will focus on oncology. The strategic …

News

J&J ‘one shot’ vaccine ineffective against Delta variant, study finds

July 21, 2021
Medical Communications, Research and Development

A new study posted online on Tuesday, has found that Johnson & Johnson’s COVID-19 vaccine is much less effective against …

News

More than 13,000 women report period changes after COVID vaccine

July 21, 2021
Research and Development COVID, Vaccine, menstruation, periods

The number of women who have reported changes to their period to the MHRA after having the COVID vaccine has …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026